Redmile Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Redmile Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-385,984	Closed	-$9.68M	–	74
2017 Q4	$9.68M	Buy	+385,984	New	+$11.9M	0.42%	51

Other funds holding ASXC

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Redmile Group's ASXC Position: Q1 2018 in Review

Redmile Group sold out of Asensus Surgical, Inc. (ASXC) in Q1 2018, closing a stake of 385,984 shares — an estimated $9.68M sold.

Redmile Group first reported a position in ASXC in Q4 2017 and held it in 1 quarter. The position peaked at $9.68M in Q4 2017. 95 funds tracked by Wall St. Rank hold ASXC as of Q1 2018.

Redmile Group reported no remaining Asensus Surgical, Inc. position as of Q1 2018 after selling out during the quarter.
Redmile Group sold 385,984 Asensus Surgical, Inc. shares in Q1 2018, an estimated $9.68M.
Redmile Group first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 1 quarter.
Redmile Group's Asensus Surgical, Inc. position peaked at $9.68M in Q4 2017.
95 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2018.

Based on Redmile Group's 13F filing for Q1 2018, filed 15 May 2018.